Biologics Market Access Director — Payer Strategy & Launch

PolarityTE, Inc.; Salt Lake City (UT); On-site; USD 180,000 - 260,000; Full time

Job summary

PolarityTE, Inc. is preparing to launch SkinTE, an autologous multicellular biologic for chronic wounds.

The Director, Market Access will own payer strategy, coding, coverage, and payment pathways to enable access at launch and beyond, coordinating with MACs, providers, and payers to optimize access and pricing. This hands-on leadership role will drive reimbursement operations, vendor oversight, and field reimbursement capabilities, partnering with Medical Affairs and HEOR to align evidence with

Qualifications

• Experience with BLA biologics and buy-and-bill reimbursement.
• Proven ability to secure coverage and payment via MAC engagement.
• Experience managing payer strategy across commercial and government channels.
• Willingness to travel for payer, provider, and conference engagements.

Responsibilities

• Develop national and regional payer strategies across Medicare, Medicaid, and commercial channels.
• Lead payer contracting and MAC engagement for coverage and pricing.
• Monitor CMS policy, OPPS/MPFS updates and translate into launch implications.
• Lead PIE with payers and transition to health care economic information (HCEI) communications.
• Build field reimbursement capability and provide materials and training.
• Manage market access vendors and ensure service levels and compliance.

Skills

Payer strategy

Vendor management

Leadership

Regulatory/compliance

Education

Bachelor's degree

Advanced degree (MBA, MPH, PharmD, or equivalent)

Job description

PolarityTE, Inc. is preparing to launch SkinTE, an autologous multicellular biologic for chronic wounds.

The Director, Market Access will own payer strategy, coding, coverage, and payment pathways to enable access at launch and beyond, coordinating with MACs, providers, and payers to optimize access and pricing. This hands-on leadership role will drive reimbursement operations, vendor oversight, and field reimbursement capabilities, partnering with Medical Affairs and HEOR to align evidence with